Julie Morgan

And the CFO of Wells Fargo & Company will present at the UBS Financial Services Conference.

On Wall Street at this early hour, Dow S&P and Nasdaq futures are in the green.

Crude oil is little changed at $64 a barrel.

Bitcoin is down 1.7% at $68,000.

Gold is down 0.1% at $50.53.

The FTSE 100 is down 0.4% and the DAX is up 0.2%.

Upwork is on our list of the biggest movers of the day pre-market.

UPWK is down 24% after the company posted mixed Q4 results and issued weaker-than-expected near-term guidance, overshadowing a more constructive full-year outlook.

And on today's economic calendar, I have two items to tell you about.

At 8.30 a.m., retail sales.

Also at 8.30 a.m., the employment cost index.

Welcome to Seeking Alpha's Wall Street Breakfast, where we cover the top news for investors every morning.

It's good to be with you on this Seattle Seahawks Monday, February 9th.

I'm Julie Morgan.

HIMS and HERS Health is on our biggest movers list ahead of market opening.

HIMS is down 15% in pre-market action.

We told you Sunday on Wall Street Brunch that HIMS said it will stop offering a compounded copycat version of Novo Nordisk WeGoV pill, following pressure from Novo and heightened FDA scrutiny.

In a post on X, the company said it decided to discontinue the treatment after constructive conversations with industry stakeholders.

The move comes after the commissioner of the FDA said regulators would target companies producing mass-market copycat drugs, which raises broader concerns around compounded GLP-1 offerings.

Novo Nordisk is up 7 percent in pre-market action following the announcement.